Download Free Sample Report

A continuous glucose monitor is a device used for monitoring blood glucose on a continual basis by people with type I diabetes.
This report contains market size and forecasts of Continuous Glucose Monitoring (CGM) in global, including the following market information:

• Global Continuous Glucose Monitoring (CGM) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Continuous Glucose Monitoring (CGM) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Continuous Glucose Monitoring (CGM) companies in 2021 (%)

The global Continuous Glucose Monitoring (CGM) market was valued at 12950 million in 2021 and is projected to reach US$ 18810 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transmitters Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Continuous Glucose Monitoring (CGM) include Pfizer, Baxter, Abbott Laboratories, Medtronic, Animas, Novo Nordisk, Ypsomed and GlySens, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Glucose Monitoring (CGM) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Glucose Monitoring (CGM) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) Market Segment Percentages, by Type, 2021 (%)

• Transmitters
• Sensors
• Insulin Pumps

Global Continuous Glucose Monitoring (CGM) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare Settings
• Others

Global Continuous Glucose Monitoring (CGM) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Continuous Glucose Monitoring (CGM) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Continuous Glucose Monitoring (CGM) revenues share in global market, 2021 (%)
• Key companies Continuous Glucose Monitoring (CGM) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Continuous Glucose Monitoring (CGM) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Baxter
• Abbott Laboratories
• Medtronic
• Animas
• Novo Nordisk
• Ypsomed
• GlySens